Leisure Products

CH ENV TECH&BIO

CH ENV TECH & BIO released FY2025 9 Months earnings on March 31 (BJT), actual revenue HKD 369.08 M, actual EPS HKD 0.3087

CH ENV TECH & BIO released FY2025 Q3 earnings on March 31 (BJT), actual revenue HKD 153.06 M, actual EPS HKD 0.2059

CH ENV TECH & BIO released FY2025 Q4 earnings on March 31 After-Market (BJT), actual revenue HKD 155.71 M, actual EPS HKD 0.2094

CH ENV TECH & BIO released FY2025 Annual Earnings on March 31 After-Market (BJT), Actual Revenue: HKD 524.13M, Actual EPS: HKD 0.5209

CH ENV TECH & BIO FY2025 Earnings Release Scheduled for March 31, 2026 After-Market BJT

CH ENV TECH&BIO released FY2025 Q1 earnings on August 29, 2025 (BJT) with actual revenue of HKD 106.84 M and EPS of HKD 0.0508

CH ENV TECH & BIO released FY2025 Semi-Annual Earnings on August 29 After-Market (BJT), actual revenue HKD 216.02 M, actual EPS HKD 0.1028

CH ENV TECH & BIO released FY2025 Q2 earnings on August 29 After-Market (BJT), actual revenue HKD 109.18 M, actual EPS HKD 0.0519

CH ENV TECH&BIO FY2025 Semi-Annual Earnings Release on August 29, 2025 (BJT)

CH ENV TECH&BIO released FY2024 Q3 earnings on March 31 (BJT), with actual revenue of 123.66 M HKD and EPS of 0.0274 HKD

CH ENV TECH&BIO released FY2024 9 Months Earnings on March 31, 2025 (BJT) with actual revenue of 324.92 M HKD and EPS of 0.0076 HKD

CH ENV TECH&BIO released FY2024 annual earnings on March 31 After-Market (BJT), actual revenue 443.4 M HKD, actual EPS 0.0324 HKD

CH ENV TECH&BIO released FY2024 Q4 earnings on March 31 After-Market (BJT), actual revenue 118.69 M HKD, actual EPS 0.0263 HKD

Zhongke Biological Expects to Achieve a Net Profit of 3 Million RMB in 2024, Turning Loss into Profit

CH ENV TECH&BIO to Release FY2024 Earnings on March 31 After-Market BJT

Zhongke Biology Changes Auditor

CH ENV TECH & BIO released FY2024 Semi-Annual Earnings on August 30 BJT, actual revenue HKD 201.25 M, actual EPS HKD -0.02

CH ENV TECH & BIO released FY2024 Q2 earnings on August 30 (BJT) with actual revenue of HKD 100.19 M and EPS of HKD -0.0099

CH ENV TECH & BIO released FY2024 Q1 earnings on August 30, 2024 (BJT) with actual revenue of HKD 101.06 M and EPS of HKD -0.01

Zhongke Biological Grants 3.9 Million Shares to Employees to Incentivize Talent

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

300765

01237

The Beijing Stock Exchange released an announcement on the evening of April 9, announcing that Zhongkeyi will adopt the offline inquiry method for its issuance. This marks the Beijing Stock Exchange's restart of offline inquiry-based issuance after a three-year hiatus, the first such instance since the issuance of Inovance in March 2023

Wallstreetcn

CSPC Innovation

Beijing Stock Exchange Restarts Inquiry-Based Issuance After Three Years

CH ENV TECH&BIO announced its full-year results for the year ended December last year, with a revenue of RMB 480 million, an increase of 17.1% year-on-year. The net profit was RMB 44.701 million, an increase of 1398.5% year-on-year; earnings per share were RMB 0.48. No dividend was declared

AASTOCKS

In the performance report, CH ENV TECH&BIO's net profit for the year is RMB 44.701 million

08270

02208

02562

08186

02405

01709

01396

02659

Hong Kong stock market overview in the past hour: Market sentiment has experienced significant fluctuations in a short period, with the energy and technology sectors standing out. The sharp decline of China Coalbed Methane has attracted widespread attention, suggesting that funds are withdrawing from the energy sector, while the strong rise of Goldwind indicates a market preference for green energy. Meanwhile, the pharmaceutical sector shows a clear divergence in performance, with some individual stocks under pressure, reflecting a cautious attitude from investors. In the past hour, the stock with the largest abnormal movement, China Coalbed Methane, saw a decline of 20.63%, becoming the focus of market attention. The rapid withdrawal of funds has put pressure on the stock price, and market sentiment appears tense, with investors taking a wait-and-see approach regarding the future trend of this stock. Strong stocks: 1. Goldwind: up 17.67%, the green energy concept is favored by the market, with significant fund inflow. 2. Synagistics: up 17.61%, short-term funds are active, and market sentiment is high. 3. Almana: up 15.54%, increased fund attention, and stock price volatility has intensified. 4. DL Holdings GP: up 10.78%, the market holds an optimistic view on its future development, with significant fund inflow. 5. GD-HKGBA HLDGS: up 10.47%, the regional development concept is attracting market attention, with active fund inflow. Stocks under pressure: 1. POWERWIN TECH: down 15.38%, the market holds a cautious view on its future development, with significant fund outflow. 2. CH ENV TECH&BIO: down 14.00%, the pharmaceutical sector shows clear divergence, with significant signs of fund withdrawal

HK Stock Alerts

CHINA CBM

GOLDWIND

SYNAGISTICS

ALMANA

POWERWIN TECH

DL HOLDINGS GP

GD-HKGBA HLDGS

BAO PHARMA-B

Hong Kong stock movement quick report: GOLDWIND leads with a 17% increase, SYNAGISTICS and ALMANA both rise, while CHINA CBM plummets by 20%

According to the Zhitong Finance APP, CH ENV TECH&BIO released its mid-term results for 2025, with revenue of 199.5 million yuan (RMB, the same below), an increase of 6.98% year-on-year; profit attributable to shareholders was 8.752 million yuan, compared to a loss of 1.715 million yuan in the same period last year, achieving a turnaround; basic earnings per share were 0.095 yuan

Zhitong

CH ENV TECH&BIO released its interim results, with a profit attributable to shareholders of HKD 8.752 million, turning from a loss to a profit year-on-year

According to the announcement from CH ENV TECH&BIO, for the six months ending June 30, 2025, the group expects to achieve a net profit attributable to shareholders of approximately RMB 9 million (for the six months ending June 30, 2024: a net loss of RMB 1.7 million). The group has turned a loss into a profit, mainly due to the recognition of foreign exchange gains of approximately RMB 16 million for the six months ending June 30, 2024

CH ENV TECH&BIO issues a profit warning, expecting a net profit attributable to shareholders of approximately 9 million yuan in the interim

01080

01160

As of the close on August 4th, 52 stocks in the Hong Kong stock market reached a 52-week high. Among them, ZHONGZHENG INTL ranked first with a high rate of 69.01%, followed by SHENGLI PIPE and CH ENV TECH&BIO at 35.62% and 26.58%, respectively. Other outstanding performers include LiFeng (Group) and GOLDSTONE CAP

SHENGLI PIPE

GOLDSTONE CAP

Zhitong Hong Kong Stock 52-week New Highs and Lows Statistics | August 4

At the Hong Kong stock market's midday close, the Hang Seng Index rose by 0.49%, the Tech Index increased by 0.93%, and CH ENV TECH&BIO surged over 40%

Hong Kong Stock Market Mid-Session Review: Hang Seng Index rose by 0.49%, Tech Index rose by 0.93%

According to the Zhitong Finance APP, CH ENV TECH&BIO released its annual performance report for the year ending December 31, 2024, with group revenue of RMB 410 million, a year-on-year increase of 37.67%; net profit of RMB 2.983 million, turning a profit from a loss year-on-year; earnings per share of RMB 0.03

CH ENV TECH&BIO released its annual performance report, with a net profit of 2.983 million yuan, turning a profit compared to the same period last year

According to the Zhitong Finance APP, CH ENV TECH&BIO announced that for the year ending December 31, 2024, the group expects to achieve a net profit attributable to shareholders of approximately RMB 3 million (2023: net loss of RMB 2.4 million). The group has turned a profit mainly due to the reversal of excess provisions for income tax expenses from the previous year amounting to approximately RMB 8.8 million

CH ENV TECH&BIO issues a profit warning, expecting a net profit attributable to shareholders of approximately 3 million yuan for the fiscal year 2024

CH ENV TECH&BIO(01237.HK)